William Pridgen
CIK: 0001826115
William Pridgen's purchase track record
How the stock did after each of William Pridgen's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
6
of 6 since December 21, 2021
Stock higher 6 months later
17%
3 months: 17%
Median 6-month return
-47.0%
3 months: -18.1%
Beat the S&P 500
17%
median -41.8% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/21/2023 | DWTX | $20K | -42.7% | -66.4% | +13.1% |
| 5/17/2022 | DWTX | $60K | +48.1% | -93.2% | -2.4% |
| 3/23/2022 | DWTX | $15K | -19.4% | -90.9% | -14.9% |
| 1/27/2022 | DWTX | $25K | -33.1% | +18.2% | -5.9% |
| 1/3/2022 | DWTX | $12K | -16.8% | -27.7% | -20.1% |
| 12/21/2021 | DWTX | $50K | -4.8% | -26.5% | -19.0% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| DWTX | ▲ Buy | Open Market | 15,335 | $20K | 8/21/2023 | View on chart |
| DWTX | ▲ Buy | Open Market | 241 | $1K | 5/18/2022 | View on chart |
| DWTX | ▲ Buy | Open Market | 13,450 | $59K | 5/17/2022 | View on chart |
| DWTX | ▲ Buy | Open Market | 600 | $3K | 3/29/2022 | View on chart |
| DWTX | ▲ Buy | Open Market | 2,197 | $12K | 3/23/2022 | View on chart |
| DWTX | ▲ Buy | Open Market | 4,180 | $25K | 1/27/2022 | View on chart |
| DWTX | ▲ Buy | Open Market | 2,215 | $12K | 1/3/2022 | View on chart |
| DWTX | ▲ Buy | Open Market | 8,827 | $50K | 12/21/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
Dogwood to Join 2026 Maxim Growth Summit
Dogwood Therapeutics announced it will participate in the 2026 Maxim Growth Summit. The event is aimed at showcasing companies to investors and partners. Participation may raise the company’s profile and provide networking opportunities. The announcement comes as the stock trades near its 14‑touch support level.
Dogwood to Join 2026 Maxim Growth Summit. Dogwood Therapeutics announced it will participate in the 2026 Maxim Growth Summit. The event is aimed at showcasing companies to investors and partners. Participation may raise the company’s profile and provide networking opportunities. The announcement comes as the stock trades near its 14‑touch support level.